COVID-19 vaccination associated with reduced risk of long COVID, NIHR

An NIHR-supported study of more than 28,000 people has shown that vaccination against COVID-19 is associated with a moderate reduction in the risk of experiencing long COVID. The study found that a first vaccine dose reduced the likelihood of long COVID symptoms by more than 12% in people who had tested positive for COVID-19 before vaccination. A second dose was associated with a further 9% reduction in the odds of long COVID. Some people who get COVID-19 experience symptoms that last weeks or months after the infection has gone, a condition known as post-COVID-19 syndrome or ' long COVID ' . Preliminary research suggests that people who get COVID-19 after vaccination are less likely to have symptoms long COVID, but the effectiveness of vaccination on pre-existing long COVID symptoms is less clear.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news